BioMarin Pharma (BMRN) Tops Q3 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. WDAY
2. AAPL
3. JNJ
4. META
5. NRIX
6. SUNS
7. SNDX
8. OIG
9. ACI
10. MRVL

Go back to BioMarin Pharma (BMRN) Tops Q3 EPS by 4c

BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $84 at Oppenheimer

October 28, 2021 6:20 AM EDT

Oppenheimer analyst Leland Gershell raised the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $84.00 (from $81.00) while maintaining a Perform rating.

The analyst commented, "Much of 3Q21's revenue lightness ($408.7M vs. our/cons $413.8/435.3M) was attributed to order/shipment timing (Aldurazyme,... More